7-Bromo-8-fluoro-3-methyl-3,4-dihydroquinoxalin-2(1H)-one, 10g

(R)-6-((1R,3aS,7aR,E)-4-((Z)-2-((3S,5R)-3,5-bis(tert-butyldimethylsilyloxy)-2-methylenecyclohexylidene)ethylidene)-7a-methyloctahydro-1H-inden-1-yl)-2-methylheptan-2-ol, 98%, 250mg

3-nitro-1-propyl-1H-pyrazole-4-carboxylic acid, 1g

2-(2,5-dimethoxyphenyl)-1,3-dioxoisoindoline-5-carboxylic acid, 5g

N-Boc-2-(2-methylamino-ethoxy)-ethylamine x HCl, 98.0%, 5g

4-CHLORO-5-METHOXYQUINAZOLINE, 95.0%, 1g

2-(trans-3-((tert-Butoxycarbonyl)amino)cyclobutyl)acetic acid, 95, 1g

Bicyclo[4.1.0]heptane-7-carboxylic acid, 97%, 1g

2-Chloro-5-hydroxynicotinic acid, 95.0%, 100mg

Tris(2,2,6,6-tetramethyl-3,5-heptanedionato)europium(III) [NMR Shift Reagent]>95.0%(T)5g

Tert-butyl 3,3-difluoro-4-methylpiperidine-1-carboxylate, 97%, 1g

fmoc-b-homo-ser(tbu)-oh, 95.0%, 250mg

1-Boc-Homopiperazine hydrochloride, 95.0%, 5g